Flavivirus RNA cap methyltransferase: Structure, function, and inhibition

Lihui Liu, Hongping Dong, Hui Chen, Jing Zhang, Hua Ling, Zhong Li, Pei-Yong Shi, Hongmin Li

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Many flaviviruses are significant human pathogens. The plus-strand RNA genome of a flavivirus contains a 5′ terminal cap 1 structure (m7GpppAmG). The flavivirus encodes one methyltransferase (MTase), located at the N-terminal portion of the NS5 RNA-dependent RNA polymerase (RdRp). Here we review recent advances in our understanding of flaviviral capping machinery and the implications for drug development. The NS5 MTase catalyzes both guanine N7 and ribose 2′-OH methylations during viral cap formation. Representative flavivirus MTases, from dengue, yellow fever, and West Nile virus (WNV), sequentially generate GpppA → m7GpppA → m7GpppAm. Despite the existence of two distinct methylation activities, the crystal structures of flavivirus MTases showed a single binding site for S-adenosyl-L-methionine (SAM), the methyl donor. This finding indicates that the substrate GpppA-RNA must be repositioned to accept the N7 and 2′-O methyl groups from SAM during the sequential reactions. Further studies demonstrated that distinct RNA elements are required for the methylations of guanine N7 on the cap and of ribose 2′-OH on the first transcribed nucleotide. Mutant enzymes with different methylation defects can trans complement one another in vitro, demonstrating that separate molecules of the enzyme can independently catalyze the two cap methylations in vitro. In the context of the infectious virus, defects in both methylations, or a defect in the N7 methylation alone, are lethal to WNV. However, viruses defective solely in 2′-O methylation are attenuated and can protect mice from later wild-type WNV challenge. The results demonstrate that the N7 methylation activity is essential for the WNV life cycle and, thus, methyltransferase represents a novel and promising target for flavivirus therapy.

Original languageEnglish (US)
Pages (from-to)286-303
Number of pages18
JournalFrontiers of Biology in China
Volume5
Issue number4
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

RNA Caps
Flavivirus
methyltransferases
Methyltransferases
methylation
Methylation
RNA
West Nile virus
defect
S-Adenosylmethionine
S-adenosylmethionine
Ribose
ribose
guanine
Guanine
virus
RNA-directed RNA polymerase
Yellow fever virus
drug development
yellow fever

Keywords

  • Flavivirus NS5
  • inhibitor
  • methyltransferase
  • RNA cap methylation
  • structure and function

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Biotechnology
  • Genetics
  • Ecology

Cite this

Liu, L., Dong, H., Chen, H., Zhang, J., Ling, H., Li, Z., ... Li, H. (2010). Flavivirus RNA cap methyltransferase: Structure, function, and inhibition. Frontiers of Biology in China, 5(4), 286-303. https://doi.org/10.1007/s11515-010-0660-y

Flavivirus RNA cap methyltransferase : Structure, function, and inhibition. / Liu, Lihui; Dong, Hongping; Chen, Hui; Zhang, Jing; Ling, Hua; Li, Zhong; Shi, Pei-Yong; Li, Hongmin.

In: Frontiers of Biology in China, Vol. 5, No. 4, 2010, p. 286-303.

Research output: Contribution to journalReview article

Liu, Lihui ; Dong, Hongping ; Chen, Hui ; Zhang, Jing ; Ling, Hua ; Li, Zhong ; Shi, Pei-Yong ; Li, Hongmin. / Flavivirus RNA cap methyltransferase : Structure, function, and inhibition. In: Frontiers of Biology in China. 2010 ; Vol. 5, No. 4. pp. 286-303.
@article{0c1fec3e8d1841ce96184c2faf2c73f2,
title = "Flavivirus RNA cap methyltransferase: Structure, function, and inhibition",
abstract = "Many flaviviruses are significant human pathogens. The plus-strand RNA genome of a flavivirus contains a 5′ terminal cap 1 structure (m7GpppAmG). The flavivirus encodes one methyltransferase (MTase), located at the N-terminal portion of the NS5 RNA-dependent RNA polymerase (RdRp). Here we review recent advances in our understanding of flaviviral capping machinery and the implications for drug development. The NS5 MTase catalyzes both guanine N7 and ribose 2′-OH methylations during viral cap formation. Representative flavivirus MTases, from dengue, yellow fever, and West Nile virus (WNV), sequentially generate GpppA → m7GpppA → m7GpppAm. Despite the existence of two distinct methylation activities, the crystal structures of flavivirus MTases showed a single binding site for S-adenosyl-L-methionine (SAM), the methyl donor. This finding indicates that the substrate GpppA-RNA must be repositioned to accept the N7 and 2′-O methyl groups from SAM during the sequential reactions. Further studies demonstrated that distinct RNA elements are required for the methylations of guanine N7 on the cap and of ribose 2′-OH on the first transcribed nucleotide. Mutant enzymes with different methylation defects can trans complement one another in vitro, demonstrating that separate molecules of the enzyme can independently catalyze the two cap methylations in vitro. In the context of the infectious virus, defects in both methylations, or a defect in the N7 methylation alone, are lethal to WNV. However, viruses defective solely in 2′-O methylation are attenuated and can protect mice from later wild-type WNV challenge. The results demonstrate that the N7 methylation activity is essential for the WNV life cycle and, thus, methyltransferase represents a novel and promising target for flavivirus therapy.",
keywords = "Flavivirus NS5, inhibitor, methyltransferase, RNA cap methylation, structure and function",
author = "Lihui Liu and Hongping Dong and Hui Chen and Jing Zhang and Hua Ling and Zhong Li and Pei-Yong Shi and Hongmin Li",
year = "2010",
doi = "10.1007/s11515-010-0660-y",
language = "English (US)",
volume = "5",
pages = "286--303",
journal = "Frontiers in Biology",
issn = "1674-7984",
publisher = "Higher Education Press",
number = "4",

}

TY - JOUR

T1 - Flavivirus RNA cap methyltransferase

T2 - Structure, function, and inhibition

AU - Liu, Lihui

AU - Dong, Hongping

AU - Chen, Hui

AU - Zhang, Jing

AU - Ling, Hua

AU - Li, Zhong

AU - Shi, Pei-Yong

AU - Li, Hongmin

PY - 2010

Y1 - 2010

N2 - Many flaviviruses are significant human pathogens. The plus-strand RNA genome of a flavivirus contains a 5′ terminal cap 1 structure (m7GpppAmG). The flavivirus encodes one methyltransferase (MTase), located at the N-terminal portion of the NS5 RNA-dependent RNA polymerase (RdRp). Here we review recent advances in our understanding of flaviviral capping machinery and the implications for drug development. The NS5 MTase catalyzes both guanine N7 and ribose 2′-OH methylations during viral cap formation. Representative flavivirus MTases, from dengue, yellow fever, and West Nile virus (WNV), sequentially generate GpppA → m7GpppA → m7GpppAm. Despite the existence of two distinct methylation activities, the crystal structures of flavivirus MTases showed a single binding site for S-adenosyl-L-methionine (SAM), the methyl donor. This finding indicates that the substrate GpppA-RNA must be repositioned to accept the N7 and 2′-O methyl groups from SAM during the sequential reactions. Further studies demonstrated that distinct RNA elements are required for the methylations of guanine N7 on the cap and of ribose 2′-OH on the first transcribed nucleotide. Mutant enzymes with different methylation defects can trans complement one another in vitro, demonstrating that separate molecules of the enzyme can independently catalyze the two cap methylations in vitro. In the context of the infectious virus, defects in both methylations, or a defect in the N7 methylation alone, are lethal to WNV. However, viruses defective solely in 2′-O methylation are attenuated and can protect mice from later wild-type WNV challenge. The results demonstrate that the N7 methylation activity is essential for the WNV life cycle and, thus, methyltransferase represents a novel and promising target for flavivirus therapy.

AB - Many flaviviruses are significant human pathogens. The plus-strand RNA genome of a flavivirus contains a 5′ terminal cap 1 structure (m7GpppAmG). The flavivirus encodes one methyltransferase (MTase), located at the N-terminal portion of the NS5 RNA-dependent RNA polymerase (RdRp). Here we review recent advances in our understanding of flaviviral capping machinery and the implications for drug development. The NS5 MTase catalyzes both guanine N7 and ribose 2′-OH methylations during viral cap formation. Representative flavivirus MTases, from dengue, yellow fever, and West Nile virus (WNV), sequentially generate GpppA → m7GpppA → m7GpppAm. Despite the existence of two distinct methylation activities, the crystal structures of flavivirus MTases showed a single binding site for S-adenosyl-L-methionine (SAM), the methyl donor. This finding indicates that the substrate GpppA-RNA must be repositioned to accept the N7 and 2′-O methyl groups from SAM during the sequential reactions. Further studies demonstrated that distinct RNA elements are required for the methylations of guanine N7 on the cap and of ribose 2′-OH on the first transcribed nucleotide. Mutant enzymes with different methylation defects can trans complement one another in vitro, demonstrating that separate molecules of the enzyme can independently catalyze the two cap methylations in vitro. In the context of the infectious virus, defects in both methylations, or a defect in the N7 methylation alone, are lethal to WNV. However, viruses defective solely in 2′-O methylation are attenuated and can protect mice from later wild-type WNV challenge. The results demonstrate that the N7 methylation activity is essential for the WNV life cycle and, thus, methyltransferase represents a novel and promising target for flavivirus therapy.

KW - Flavivirus NS5

KW - inhibitor

KW - methyltransferase

KW - RNA cap methylation

KW - structure and function

UR - http://www.scopus.com/inward/record.url?scp=77956126053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956126053&partnerID=8YFLogxK

U2 - 10.1007/s11515-010-0660-y

DO - 10.1007/s11515-010-0660-y

M3 - Review article

AN - SCOPUS:77956126053

VL - 5

SP - 286

EP - 303

JO - Frontiers in Biology

JF - Frontiers in Biology

SN - 1674-7984

IS - 4

ER -